HSBC Holdings’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

HSBC Holdings’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-704,537	Closed	-$17.1M	–	2864
2023 Q1	$17.1M	Buy	+704,537	New	+$8.84M	0.02%	659
2021 Q4	–	Sell	-23,352	Closed	-$150K	–	3402
2021 Q3	$150K	Buy	23,352 +10,385	+80%	+$66.7K	﹤0.01%	2836
2021 Q2	$110K	Buy	12,967 +2,475	+24%	+$20K	﹤0.01%	2842
2021 Q1	$109K	Buy	+10,492	New	+$148K	﹤0.01%	2628

Other funds holding PRVB

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

HSBC Holdings's PRVB Position: Q2 2023 in Review

HSBC Holdings sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 704,537 shares — an estimated $17.1M sold.

HSBC Holdings first reported a position in PRVB in Q1 2021 and held it in 4 quarters. The position peaked at $17.1M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

HSBC Holdings reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
HSBC Holdings sold 704,537 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $17.1M.
HSBC Holdings first reported a position in Provention Bio, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
HSBC Holdings's Provention Bio, Inc. Common Stock position peaked at $17.1M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on HSBC Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.